Myocarditis Secondary to COVID 19 Infection: A Case-Report
International Journal of Medical and Pharmaceutical Case Reports,
Introduction: Coronavirus disease 2019 (COVID 19) is an emerging viral infection caused by the strain of coronavirus SARS-CoV-2, primarily affecting the respiratory system. However, it can be responsible for heart damage.
The aim of this work was to report a case of symptomatic myocarditis in a 53-year-old patient.
Patient and Observation: We report the case of a 53-year-old patient with no particular history or cardiovascular risk factor found who had consulted in June 2020 in a hospital for dyspnea, dizziness and palpitations in whom the electrocardiogram had demonstrated ventricular tachycardia. The echocardiography was normal and coronary artery disease was ruled out on coronary angiography and antiarrhythmic treatment allowed it to regress. Two months later, after a break in therapy, this tachycardia recurred despite several electrical and chemical cardioversions. Subsequently, myocarditis was suspected. This motivated the realization of a cardiac magnetic resonance imaging (MRI) which came back in favor of myocarditis. As part of the etiological research, RT-PCR and COVID 19 serology were requested and the serology returned positive for IgG.
Conclusion: COVID 19 disease is known for its respiratory manifestations. However, several cases of cardiac involvement, in particular myocardial damage, have been described and among these, a considerable proportion of arrhythmias. They can be multifactorial in origin, due to the virus itself, or the prolongation of the QT interval from various drug therapies. These arrhythmias are the source of sudden death, hence the interest of RT-PCR and COVID 19 serology, but also the need for early and appropriate management, as well as long-term monitoring of patients. cured patients.
- COVID 19
- ventricular tachycardia
How to Cite
He J, Wu B, Chen Y, et al. Characteristic electrocardiographic manifestations in patients With COVID-19 J Cardiol. 2020;36:966.e1-966.e4
Chen G, Wu D, Guo W, et al. Clinical and immunologic features in severe and moderate forms of coronavirus disease 2019 J Clin Invest. 2020;130:2620- 2629
Han Y, Chen T, Bryant J, et al. Society for Cardiovascular Magnetic Resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic J Cardiovasc Magn Reson. 2020;22:26.
Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper J Am Coll Cardiol. 2009;53:1475-1487.
Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020 ;22:911-915
Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) [e-pub ahead of print]. JAMA Cardiol .
Fairweather D, Cooper LTJ, Blauwet LA. Sex and gender differences in myocarditis and dilated cardiomyopathy Curr Probl Cardiol. 2013;38:7-46
Coyle J, Igbinomwanhia E, Sanchez-Nadales A, et al. A recovered case of COVID-19 myocarditis and ARDS treated with corticosteroids, tocilizumab, and experimental AT-001 [e-pub ahead of print]. JACC Case Rep.
Caforio ALP, Pankuweit S, Arbustini E, et al. Current state of knowledge on etiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J. 2013;34:2636-2648;2648a-d
Abstract View: 50 times
PDF Download: 20 times